Prestige Consumer Healthcare Inc
Company Profile
Business description
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Contact
660 White Plains Road
TarrytownNY10591
USAT: +1 914 524-6800
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
600
Stocks News & Analysis
stocks
WiseTech result disappoints, but the future looks bright
stocks
WOW earnings: Woolworths losing market share, but will catch up to Coles
stocks
Chart of the Week: Largest share price falls during earnings
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,213.40 | 28.20 | -0.31% |
CAC 40 | 7,743.93 | 34.12 | 0.44% |
DAX 40 | 24,046.21 | 106.66 | -0.44% |
Dow JONES (US) | 45,565.23 | 147.16 | 0.32% |
FTSE 100 | 9,255.50 | 10.30 | -0.11% |
HKSE | 25,033.23 | 168.53 | -0.67% |
NASDAQ | 21,590.14 | 45.87 | 0.21% |
Nikkei 225 | 42,614.21 | 93.94 | 0.22% |
NZX 50 Index | 12,856.22 | 5.62 | -0.04% |
S&P 500 | 6,481.40 | 15.46 | 0.24% |
S&P/ASX 200 | 8,949.80 | 20.70 | -0.23% |
SSE Composite Index | 3,796.71 | 3.64 | -0.10% |